11 – 20 of 96
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2022
 - 
                        Mark
        A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Patient-associated mutations in Drosophila Alk perturb neuronal differentiation and promote survival
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        The immune cell atlas of human neuroblastoma
    
    
- Contribution to journal › Article
 
 - 2021
 - 
                        Mark
        Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research
    (2021) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 149. p.1-13
- Contribution to journal › Article
 
 - 
                        Mark
        Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma : What now?
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Anti-tumor effects of rigosertib in high-risk neuroblastoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
    (2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
 
 - 2020
 - 
                        Mark
        ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Gene expression signature of acquired chemoresistance in neuroblastoma cells
    
    
- Contribution to journal › Article
 
 
